Today, PET/CT technology is regarded as the most powerful tool to accurately depict and measure the metabolic function of cancer. It has become a leading diagnostic instrument for breast, lung, colon and prostate cancers. For cardiology applications, PET/CT scanning is the most accurate noninvasive test to determine the presence of coronary artery disease or the viability of the muscle. PET/CT imaging also can be used to detect abnormalities in the brain, making it easier to diagnose neurological disorders. It promptly identifies diseases and provides a timely, accurate diagnosis - eliminating the need to subject a patient to a battery of testing procedures before beginning treatment. Earlier treatment often correlates with better outcomes.
Shields Health Care Group operates more than 25 medical imaging locations throughout Massachusetts, including several locations that specialize in PET/CT medical diagnostic imaging. Shields PET/CT facilities in Fitchburg, Springfield, Weymouth, Worcester, Sandwich, Harwich and Boston (MA) bring the most advanced PET/CT medical imaging to all the state’s major population centers outside Route 128, via the region’s best trauma centers, teaching hospitals and community hospitals.